By: Chang Ming-hsuan and Chiang Yi-ching
Under a deal Taiwan signed with COVAX in September, Taiwan will purchase at least enough doses to vaccinate 10 percent of the population, which amounts to around 2.3 million people, CECC spokesman Chuang Jen-hsiang (莊人祥) said at a press briefing.
COVAX is a global vaccine allocation plan through which countries can sign up to purchase COVID-19 vaccines. The project's aim is to accelerate the development and manufacture of the vaccines, as well as guarantee fair and equitable access to the vaccines in every country.
Currently, three vaccines developed by international companies have been confirmed to be on COVAX's portfolio, according to Chuang. [FULL STORY]